Translational studies in allergic reactions and inflammation
$3,155,225ZIAFY2023AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications, trials & patents
Paper 36884218Paper 36170795Paper 35287299Paper 35093604Paper 34896311Paper 34425177Paper 34175497Paper 34166845Paper 33970354Paper 33932709Paper 33876203Paper 33865872Paper 33753098Paper 33745886Paper 33744473Paper 33481382Paper 33401724Paper 33248113Paper 33098103Paper 32717252Paper 31981732Paper 31707513Paper 31605754Paper 31337736Paper 31319217Paper 31256161Paper 31102699Paper 30565252Paper 30007465Paper 29748908Paper 29549114Paper 29191866Paper 29033258Paper 28933792Paper 28710273Paper 28628108Paper 28126831Paper 28063873Paper 27749843Paper 27643438Paper 27388694Paper 26125015Paper 25760457Paper 25459583Paper 25359994Paper 24589341Paper 24472624
Abstract
In Fiscal Year (FY) 2023, we continued to advance our understanding of acquired and inherited genetic changes that promote mast cell reactivity, anaphylaxis, and allergic inflammation. Foremost among the advances we reported this FY, was a manuscript demonstrating the usefulness of tryptase genotyping - when used in combination with serum levels of the tryptase protein - in identifying patients with myeloid neoplasms. We also reported the impact of tryptase gene composition on the severity of food allergic reactions. And finally, as part of an international collaborative effort, we also published a landmark study on STAT6 gain-of-function in humans.
View original record on NIH RePORTER →